Hidradenitis Suppurativa Drugs Compared in Network Meta-Analysis – Physician’s Weekly
Sonelokimab, lutikizumab, and adalimumab showed the highest HiSCR-50 response rates in moderate to severe HS, per a network meta-analysis in JAMA …
The Heartbeat of World events
Sonelokimab, lutikizumab, and adalimumab showed the highest HiSCR-50 response rates in moderate to severe HS, per a network meta-analysis in JAMA …
